CD44 and cancer: Forty two pairs breast cancer and matched adjacent tissues were stained with ALDH1 or CD44 antibody in each test, to detect the potential stem cells (Figure 1A-1B), and results showing that the intensities of either ALDH1 or CD44 was much stronger in cancer tissues than that of adjacent tissues (Figure 1B-1C).